211 related articles for article (PubMed ID: 26160324)
21. Recent Apolipoprotein CIII trials.
Tramontano D; Bini S; D'Erasmo L; Arca M
Curr Opin Lipidol; 2022 Dec; 33(6):309-318. PubMed ID: 36206093
[TBL] [Abstract][Full Text] [Related]
22. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
Romeo GR; Moulton KS; Kazlauskas A
Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
[TBL] [Abstract][Full Text] [Related]
23. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
24. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
25. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
26. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein CIII and diabetes. Is there a link?
Christopoulou E; Tsimihodimos V; Filippatos T; Elisaf M
Diabetes Metab Res Rev; 2019 Mar; 35(3):e3118. PubMed ID: 30557902
[TBL] [Abstract][Full Text] [Related]
28. The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.
Borén J; Packard CJ; Taskinen MR
Front Endocrinol (Lausanne); 2020; 11():474. PubMed ID: 32849270
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein CIII links dyslipidemia with atherosclerosis.
Kawakami A; Yoshida M
J Atheroscler Thromb; 2009 Mar; 16(1):6-11. PubMed ID: 19262004
[TBL] [Abstract][Full Text] [Related]
30. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
31. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
[TBL] [Abstract][Full Text] [Related]
32. Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.
Wang J; Sjöberg S; Tia V; Secco B; Chen H; Yang M; Sukhova GK; Shi GP
Atherosclerosis; 2013 Aug; 229(2):304-9. PubMed ID: 23880180
[TBL] [Abstract][Full Text] [Related]
33. Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
Andersson KE; Svedberg KA; Lindholm MW; Oste R; Hellstrand P
Atherosclerosis; 2010 Sep; 212(1):93-9. PubMed ID: 20553794
[TBL] [Abstract][Full Text] [Related]
34. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.
Allen S; Khan S; Al-Mohanna F; Batten P; Yacoub M
J Clin Invest; 1998 Mar; 101(5):1064-75. PubMed ID: 9486977
[TBL] [Abstract][Full Text] [Related]
35. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
[TBL] [Abstract][Full Text] [Related]
36. Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro.
Sinningen K; Rauner M; Goettsch C; Al-Fakhri N; Schoppet M; Hofbauer LC
Biochem Biophys Res Commun; 2013 Jul; 437(2):314-8. PubMed ID: 23817038
[TBL] [Abstract][Full Text] [Related]
37. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
38. Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease.
Zheng C
Curr Opin Lipidol; 2014 Feb; 25(1):35-9. PubMed ID: 24345989
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice.
Rivas-Urbina A; Rull A; Aldana-Ramos J; Santos D; Puig N; Farre-Cabrerizo N; Benitez S; Perez A; de Gonzalo-Calvo D; Escola-Gil JC; Julve J; Ordoñez-Llanos J; Sanchez-Quesada JL
Biomolecules; 2020 May; 10(6):. PubMed ID: 32485898
[TBL] [Abstract][Full Text] [Related]
40. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
